11 results
8-K
EX-99.1
CRGX
CARGO Therapeutics Inc
14 May 24
CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
4:09pm
. The Company’s CRG-022 Investigational New Drug application included a comprehensive package in which CARGO performed and demonstrated analytical comparability
10-K
2023 FY
CRGX
CARGO Therapeutics Inc
21 Mar 24
Annual report
4:21pm
trial and concluded that the two are comparable. Moreover, our CRG-022 IND included our comprehensive package to establish the comparability of our … comprehensive package to establish the comparability of our intended commercial process to the process used for the Stanford clinical trial, we cannot assure
424B4
CRGX
CARGO Therapeutics Inc
13 Nov 23
Prospectus supplement with pricing info
4:31pm
included our comprehensive package to establish the comparability of our intended commercial process to the process used for the Stanford clinical trial, we … CRG-022 IND application included our comprehensive package to establish the comparability of our CRG-022 produced using the intended commercial
S-1/A
EX-10.2
7e47dhcjas91fvywq6uw
1 Nov 23
IPO registration (amended)
5:20pm
S-1
gyz9129kt5ih 8l2
20 Oct 23
IPO registration
4:07pm
DRS/A
csnbhc4gdvea
4 Oct 23
Draft registration statement (amended)
12:00am
DRS
m5vxjbnoh9f
1 Sep 23
Draft registration statement
12:00am
- Prev
- 1
- Next